TARA – protara therapeutics, inc. (US:NASDAQ)
Stock Stats
News
ASTS, CRBU and DOMO are among after hour movers [Seeking Alpha]
Protara Therapeutics to Present at the TD Cowen 5th Annual Oncology Innovation Summit
UK NICE backs Exact's Oncotype cancer genomic test Fri, May 10, 2024, 3:22 PM GMT+2 2 min read 0 In this article: Advertisement Up next These 2 ‘Strong Buy' Penny Stocks Could Surge Over 400%, Says Oppenheimer Thu, May 9, 2024, 7:20 PM GMT+2 6 min read
Protara Therapeutics, Inc. (NASDAQ: TARA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update
Form 4 Protara Therapeutics, For: Jun 07 Filed by: Solomon Michael Edward
Form 4 Protara Therapeutics, For: Jun 07 Filed by: Smith Cynthia
Form 4 Protara Therapeutics, For: Jun 07 Filed by: Flannelly Barry P
Form 4 Protara Therapeutics, For: Jun 07 Filed by: BESHAR LUKE M
Form 4 Protara Therapeutics, For: Jun 07 Filed by: GARCEAU ROGER
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.